CAMPOLO, JONICA
 Distribuzione geografica
Continente #
AS - Asia 2.346
NA - Nord America 2.253
EU - Europa 704
SA - Sud America 514
Continente sconosciuto - Info sul continente non disponibili 119
AF - Africa 47
OC - Oceania 6
Totale 5.989
Nazione #
US - Stati Uniti d'America 2.128
SG - Singapore 980
CN - Cina 451
BR - Brasile 416
VN - Vietnam 281
IT - Italia 254
HK - Hong Kong 227
FR - Francia 124
BD - Bangladesh 123
NL - Olanda 104
KR - Corea 69
CA - Canada 51
JP - Giappone 49
IN - India 44
FI - Finlandia 43
DE - Germania 42
GB - Regno Unito 42
AR - Argentina 32
MX - Messico 32
ID - Indonesia 21
EC - Ecuador 20
ZA - Sudafrica 20
CO - Colombia 14
SE - Svezia 14
JM - Giamaica 13
TR - Turchia 12
AT - Austria 10
PL - Polonia 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
ES - Italia 9
IL - Israele 9
IQ - Iraq 9
CR - Costa Rica 8
PH - Filippine 8
IE - Irlanda 7
PY - Paraguay 7
SA - Arabia Saudita 7
UA - Ucraina 7
CZ - Repubblica Ceca 6
MY - Malesia 6
PE - Perù 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
RU - Federazione Russa 5
TN - Tunisia 5
VE - Venezuela 5
AL - Albania 4
DO - Repubblica Dominicana 4
MA - Marocco 4
PK - Pakistan 4
BO - Bolivia 3
CH - Svizzera 3
EG - Egitto 3
ET - Etiopia 3
GT - Guatemala 3
HN - Honduras 3
KE - Kenya 3
LT - Lituania 3
LV - Lettonia 3
NG - Nigeria 3
NP - Nepal 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AU - Australia 2
GP - Guadalupe 2
HR - Croazia 2
IR - Iran 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
MT - Malta 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
CV - Capo Verde 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
KH - Cambogia 1
KY - Cayman, isole 1
LC - Santa Lucia 1
LK - Sri Lanka 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PF - Polinesia Francese 1
PG - Papua Nuova Guinea 1
RS - Serbia 1
SC - Seychelles 1
SV - El Salvador 1
Totale 5.866
Città #
Singapore 583
Santa Clara 482
Hong Kong 220
San Jose 193
Hefei 151
Ashburn 148
Beijing 126
Council Bluffs 104
Lauterbourg 101
Los Angeles 96
Dallas 90
Ho Chi Minh City 86
Seoul 69
New York 60
Hanoi 56
Tokyo 39
Milan 34
São Paulo 34
Buffalo 28
Helsinki 28
Rome 26
Phoenix 25
Naples 20
Cascina 17
Orem 17
Chicago 15
Da Nang 15
Toronto 15
Atlanta 14
Brooklyn 13
Frankfurt am Main 13
Stockholm 13
Johannesburg 12
Lappeenranta 12
Rio de Janeiro 12
Belo Horizonte 11
Brasília 11
Mexico City 11
Montreal 11
Florence 10
Lucca 10
Columbus 9
Denver 9
Haiphong 9
Houston 9
London 9
Curitiba 8
Dhaka 8
Hải Dương 8
Manchester 8
Turin 8
Amsterdam 7
Campinas 7
Charlotte 7
Falkenstein 7
Jacksonville 7
Memphis 7
Minamishinagawa 7
Poplar 7
Ankara 6
Bengaluru 6
Biên Hòa 6
Bogotá 6
Greenville 6
Guangzhou 6
Guayaquil 6
Las Vegas 6
Mumbai 6
New Delhi 6
Nuremberg 6
Philadelphia 6
Pittsburgh 6
Quito 6
San Francisco 6
San José 6
Tashkent 6
Vienna 6
Warsaw 6
Antioch 5
Baku 5
Boston 5
Can Tho 5
Chennai 5
Cleveland 5
Dublin 5
Düsseldorf 5
Fortaleza 5
Guarulhos 5
Jena 5
Kansas City 5
Monza 5
Palermo 5
Prague 5
Santiago 5
Santo André 5
Agrate Brianza 4
Baghdad 4
Bari 4
Barranquilla 4
Bologna 4
Totale 3.391
Nome #
SMARTool: Interim Progress Report (M19-M30) 139
Correlates of olfactory impairment in middle-aged non-diabetic Caucasian subjects with stage I-II obesity 134
SMARTool - Periodic Technical Report - PART B (Period 2) 124
Medium-term effect of sublingual L-glutathione supplementation on flow-mediated dilation in subjects with cardiovascular risk factors 116
Blood Monocyte Phenotype Fingerprint of Stable Coronary Artery Disease: A Cross-Sectional Substudy of SMARTool Clinical Trial 97
Cancer Risk in Patients With Congenital Heart Disease Exposed to Radiation From Cardiac Procedures 90
METABOLIC AND CARDIAC AUTONOMIC CORRELATES OF THE CUORE SCORE IN NON DIABETICS WITH STAGE I-II OBESITY IN LATE MIDDLE-AGE 87
Lysyl oxidase expression and collagen cross-linking during chronic adriamycin nephropathy 84
Influence of Chromosome 9p21.3 rs1333049 Variant on Telomere Length and Their Interactive Impact on the Prognosis of Coronary Artery Disease 84
Telomere Length, Mitochondrial DNA, and Micronucleus Yield in Response to Oxidative Stress in Peripheral Blood Mononuclear Cells 82
Vascular senescence and atherosclerotic plaque vulnerability: investigating the telomere-mitochondria crosstalk—rationale and design of the VICTORIA Study 80
Computing of low shear stress-driven endothelial gene network involved in early stages of atherosclerotic process 79
The burden of radiation exposure in congenital heart disease: the Italian cohort profile and bioresource collection in HARMONIC project 79
Biochemical but not imaging parameters are predictive of outcome in septic shock: a pilot study 76
A single blueberry (Vaccinium corymbosum) portion does not affect markers of antioxidant defence and oxidative stress in healthy volunteers following cigarette smoking 75
Upregulation of chemokine receptor CXCR4 and caspase-dependent apoptosis genes can synergistically favour activation of endothelial cells exposed to low shear stress 75
Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina 74
Clinical and Biological Predictors of Cancer Incidence and Mortality in Patients with Stable Coronary Artery Disease 72
Coronary blood flow, metabolism and function in dysfunctional viable myocardium before and early after surgical revascularization 71
ARTREAT Human Data Collection and Model Modifications (D4.4.1) 70
Low leptin plasma levels are associated with progression of coronary atherosclerosis in patients with stable coronary artery disease from the SMARTool Study 70
Gender-Specific Behaviour in Obesity Stages I-II: Imbalance of Aminothiol Status and Adipomyokine Profile in Subjects with Different Insulin Resistance Severity 69
Blood gluthatione as a marker of cardiac allograft vasculopathy in heart transplant recipients 67
A serving of blueberry (V. corymbosum) acutely improves peripheral arterial dysfunction in young smokers and non-smokers: two randomized, controlled, crossover pilot studies 66
Irisin and markers of metabolic derangement in non-diabetic Caucasian subjects with stage I-II obesity during early aging 66
Lo stress ossidativo e l'attivazione dell'infiammazione nello scompenso cardiaco terminale non migliorano durante la prima fase (1 mese) dopo impianto di assistenza ventricolare meccanica sinistra (LVAD) 65
The mitochondrial dysfunction, alongside the modifiable burden of traditional risk factors, drives the development of early-onset coronary artery disease 63
Myocardial interleukin-6 in the setting of left ventricular mechanical assistance: relation with outcome and C-reactive protein. 63
Time course of the modified endstage liver disease score and oxidative stress early after left ventricular assist device implant for end stage heart failure 61
SMARTool: Periodic Technical Report - Part B 61
Innate Immunity and Coronary Atherosclerosis Progression: putative cellular and molecular marker. 60
Relationship between Early Inflammatory Response and Clinical Evolution of the Severe Multiorgan Failure in Mechanical Circulatory Support-Treated Patients 58
Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD 58
Early Expression of Pro- and Anti-Inflammatory Cytokines in Left Ventricular Assist Device Recipients With Multiple Organ Failure Syndrome 57
Long Telomeric Repeat-Containing RNA (TERRA): Biological Functions and Challenges in Vascular Aging and Disease 57
A Longitudinal Study of Individual Radiation Responses in Pediatric Patients Treated with Proton and Photon Radiotherapy, and Interventional Cardiology: Rationale and Research Protocol of the HARMONIC Project 57
Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial 56
Plasma Amino Acids in NAFLD Patients with Obesity Are Associated with Steatosis and Fibrosis: Results from the MAST4HEALTH Study 56
Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer. 55
Biological and Proteomic characterization of a composite mesh for abdominal wall hernia treatment: Reference Study 55
Vascular injury post stent implantation: Different gene expression modulation in Human Umbilical Vein Endothelial Cells (HUVECs) model 53
DOREMI - Target users and scenarios of use (D2.1) 51
Time-course of plasma NT-pro C-type natriuretic peptide in end-stage heart failure patients supported by left ventricular assist device implant. 51
Coronary blood flow, metabolism and function in dysfunctional viable miocardium before and early after surgical revascularization 51
Evaluation of thiol redox status in hyperlipidemic patients on lipid-lowering and antioxidant treatment 51
GENETIC MARKERS IN CARDIAC RESYNCHRONIZATION THERAPY TREATMENT SUCCESS 50
High-performance liquid chromatographic determination of total plasma homocysteine with or without internal standards 49
Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects 49
Blood glutathione as independent marker of lipid peroxidation in heart failure 48
Intra- and interday repeatability of peripheral arterial function: suitability and potential limitations 48
Hyperlipidemia and Oxidative Stress: Evaluation Of PUFA n-3 Vitamin E and gamma-Oryzanol Combination. 47
Health effects of ionising radiation in paediatrics undergoing either cardiac fluoroscopy or modern radiotherapy (The HARMONIC project) 47
Critical study of preanalytical and analytical phase of adenine and pyridine nucleotide assay in human whole blood. 47
Urinary neopterin, a new marker of the neuroinflammatory status in amyotrophic lateral sclerosis 47
Early intra-aortic balloon pump in acute decompensated heart failure complicated by cardiogenic shock: Rationale and design of the randomized Altshock-2 trial 46
Is the Oxidant/Antioxidant Status Altered in CADASIL Patients? 46
Low plasma glutathione levels after reperfused acute myocardial infarction are associated with late cardiac events 45
Neopterin levels are independently associated with cardiac remodeling in patients with chronic heart failure 45
Cardiogenic Shock Integrated PHenotyping for Event Reduction: A Pilot Metabolomics Analysis 44
Relaxin and endothelin-1 axis in heart failure patients: First evidence of their transcriptional profiling in during left ventric- ular assist device support 43
Cardiovascular risck burden, gamma-glutamyltransferase and redox state: an emerging link 43
Genetic variants associated to reverse remodelling after cardiac resynchronization therapy 42
DOREMI - Active Ageing Lifestyle Protocol (D2.2) 42
Time-course of plasma NT-proc-type natriuretic peptide in end-stage heart failure patients supported by left ventricular assist device implant. 41
Effects of Sapropterin on Endothelium-Dependent Vasodilation in Patients With CADASIL A Randomized Controlled Trial 41
A single portion of blueberry (Vaccinium corymbosum L) improves protection against DNA damage but not vascular function in healthy male volunteers 41
Super-normal Tl-201 retention in hibernating myocardium: an ex-vivo study using the failing human heart 40
BIOLOGICAL AND INSTRUMENTAL MARKERS OF ENDOTHELIAL DYSFUNCTION IN CADASIL (CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY) 40
Plasma glutathione levels are independently associated with ?-glutamyltransferase activity in subjects with cardiovascular risk factors 39
Congenital Heart Disease and the Risk of Cancer: An Update on the Genetic Etiology, Radiation Exposure Damage, and Future Research Strategies 39
Aminothiol redox alterations in patients with chronic heart failure of ischaemic or non-ischaemic origin 39
Time-course of plasma NT-proc-type natriuretic peptide in end-stage heart failure patients supported by left ventricular assist device implant 39
Pre-operative interleukin-6 levels and pronounced postoperative inflammatory response are associated to INTERMACS profile before left ventricular assist device implantation 39
ARTREAT Human Data Collection and Coronary Model Modifications (D4.4.2) 38
Oxidative stress and thiol redox state in patients with coronary and carotid artery atherosclerosis 38
Impaired vasoreactivity in mildly disabled CADASIL patients 38
Paraoxonase 1 L55M, Q192R and paraoxonase 2 S311C alleles in atherothrombosis 37
Oxidative stress and inflammatory activation in end-stage heart failure do not ameliorate during early phase (1 month) of left ventricular mechanical assistance 37
Methionine challenge paradoxically induces a greater activation of the antioxidant defence in subjects with hyper- vs normohomocysteinemia 37
Severity of oxidative stress and inflammatory activation in end-stage heart failure patients are unaltered after 1 month of left ventricular mechanical assistance 36
Reduced myocardial MMP-2, MMP-9 and gluatione peroxidase activities and elevated cytokine levesl in patients supported by left ventricular assist device 36
Identification of genetic markers for treatment success in heart failure patients insight from cardiac resynchronization therapy 36
Glutamate-cysteine ligase polymorphism, hypertension, and male sex are associated with cardiovascular events. Biochemical and genetic characterization of Italian subpopulation 36
Antioxidant and inflammatory biomarkers for the identification of prodromal Parkinson's disease 36
Association of liver inflammation and fibrosis score with non-invasive biomarkers in non-alcoholic fatty liver disease: Preliminary results from the MAST4HEALTH study 36
Genetic variants associated to reverse remodelling after cardiac resynchronization therapy 35
The role of PON2 311 Cys allele and risk factors in atherothrombotic event 34
Pre-operative interleukin-6 levels and pronounced postoperative inflammatory response are associated to INTERMACS profile before left ventricular assist 34
In vitro effect of stent positioning on gene expression profile 34
Repeatability of arterial function by EndoPAT2000: a potential tool for studying vasoreactivity of bioactive-rich foods 34
Genetic co-regulation of neopterin and Parkinson’s disease 33
Does left ventricular assist device implantation modulate the cardiac cell apoptosis in end-stage heart failure? 33
Automated APTT cycle for the rapid identification of plasma prekallikrein deficiency 32
Genetic variants of the renin-angiotensin-aldosterone system and reverse remodeling after cardiac resynchronization therapy 31
Effect of a wild blueberry (Vaccinium angustifolium) drink intervention on markers of oxidative stress, inflammation and endothelial function in humans with cardiovascular risk factors 31
Relationship Between Myocardial Redox State and Matrix Metalloproteinase Activity in Patients on Left Ventricular Assist Device Support 31
Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer 30
Methonine challenge paradoxically induces a greater activation of the antioxidant defence in subjects with hyper-vs normohomocysteinemia 30
Myocardial redox state alterations and elevated cytokines levels in patients with end stage heart failure (ESHF) supported by left ventricular assist device (LVAD) 30
Plasma cysteine and glutathione are independent markers of postmethionine load endothelial dysfunction 30
Totale 5.414
Categoria #
all - tutte 19.791
article - articoli 15.940
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.731


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202414 0 0 0 0 0 0 0 1 1 0 12 0
2024/20251.917 3 6 130 63 399 145 84 96 56 129 445 361
2025/20263.073 129 291 319 526 578 109 374 132 123 181 186 125
2026/2027985 254 178 357 196 0 0 0 0 0 0 0 0
Totale 5.989